CDK9-IN-34 is a CDK9 inhibitor with an IC50 of 0.25 µM. CDK9-IN-34 has selective cytotoxicity against cancer cells, and has anti-coronaviral activity against human coronavirus 229E (IC50 = 145.92 µM)[1].
Molecular Weight:
292.38
Purity:
99.82
CAS Number:
[252725-86-3]
Formula:
C18H20N4
Target:
CDK,SARS-CoV
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
